Kawasaki disease: insights into pathogenesis and approaches to treatment (Q38439648)

3 September 2017

1 reference

title

Kawasaki disease: insights into pathogenesis and approaches to treatment (English)

1 reference

3 September 2017

1 reference

Stanford T Shulman

1

1 reference

3 September 2017

Anne H Rowley

series ordinal

2

1 reference

3 September 2017

language of work or name

English

0 references

publication date

28 April 2015

1 reference

Nature Reviews Rheumatology

3 September 2017

published in

1 reference

3 September 2017

volume

11

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

475-482

1 reference

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Update on Kawasaki disease: epidemiology, aetiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Oligoclonal IgA response in the vascular wall in acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Diagnosis, treatment, and long-term management of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Longstanding Obliterative Panarteritis in Kawasaki Disease: Lack of Cyclosporin A Effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Fatal Kawasaki disease caused by early occlusive coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Dilated coronary arterial lesions in the late period after Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Kawasaki disease in parents and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Epidemiological features of Kawasaki disease in Korea, 2006-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Common variants in CASP3 confer susceptibility to Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

A genome-wide association study identifies three new risk loci for Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Seven-year national survey of Kawasaki disease and acute rheumatic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

T cell activation profiles in Kawasaki syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Cloning the arterial IgA antibody response during acute Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Regression of aneurysms in Kawasaki disease: a pathological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Fatal Kawasaki disease with coronary arteritis and no coronary aneurysms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Images in cardiovascular medicine. Sudden death due to rupture of coronary aneurysm in a 26-year-old man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Two cases of new coronary aneurysms that developed in the late period after Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Expanding coronary aneurysm in the late phase of Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Images in cardiovascular medicine. Giant coronary aneurysm of Kawasaki disease developing during postacute phase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Two cases with past Kawasaki disease developing acute myocardial infarction in their thirties, despite being regarded as at low risk for coronary events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Two young adults who had acute coronary syndrome after regression of coronary aneurysms caused by Kawasaki disease in infancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits. An experimental model for Kawasaki disease in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

An evaluation of the validity of the animal models of Kawasaki disease vasculopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

CD84 is markedly up-regulated in Kawasaki disease arteriopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

High-dose intravenous gammaglobulin for Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.54

Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children

31 March 2020

1 reference

12 December 2020

Genetics of Kawasaki disease: what we know and don't know

1 reference

12 December 2020

Kawasaki disease in families

1 reference

12 December 2020

IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.

1 reference

12 December 2020

Pathology of the heart in Kawasaki disease

1 reference

12 December 2020

Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii

1 reference

12 December 2020

Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MLNS) in an infant.

1 reference

12 December 2020

Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.

1 reference

12 December 2020

Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2015.54

1 reference

Dimensions Publication ID

3 September 2017

1018529941

0 references

1 reference